786-0
|
GI50 |
|
Anticancer activity against human 786-0 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human 786-0 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
A549
|
GI50 |
|
Anticancer activity against human A549 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
Anticancer activity against human A549 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
|
[PMID: 35533562]
|
ACHN
|
GI50 |
|
Anticancer activity against human ACHN cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human ACHN cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
BT-549
|
GI50 |
|
Anticancer activity against human BT-549 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human BT-549 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
CAKI-1
|
GI50 |
|
Anticancer activity against human CAKI-1 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human CAKI-1 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
CCRF-CEM
|
GI50 |
|
Anticancer activity against human CCRF-CEM cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human CCRF-CEM cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
COLO 205
|
GI50 |
|
Anticancer activity against human COLO 205 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human COLO 205 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
DU-145
|
GI50 |
|
Anticancer activity against human DU-145 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human DU-145 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
EKVX
|
GI50 |
|
Anticancer activity against human EKVX cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human EKVX cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
HaCaT
|
GI50 |
|
Cytotoxicity against human HaCaT cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
Cytotoxicity against human HaCaT cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
|
[PMID: 35533562]
|
HCC 2998
|
GI50 |
|
Anticancer activity against human HCC 2998 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human HCC 2998 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
HCT-116
|
GI50 |
|
Anticancer activity against human HCT-116 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human HCT-116 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
HCT-116
|
GI50 |
|
Anticancer activity against human HCT-116 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
Anticancer activity against human HCT-116 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
|
[PMID: 35533562]
|
HCT-15
|
GI50 |
|
Anticancer activity against human HCT-15 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human HCT-15 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
HeLa
|
GI50 |
|
Anticancer activity against human HeLa cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
Anticancer activity against human HeLa cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
|
[PMID: 35533562]
|
HL-60
|
GI50 |
|
Anticancer activity against human HL-60 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human HL-60 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
HOP-62
|
GI50 |
|
Anticancer activity against human HOP-62 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human HOP-62 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
HOP-92
|
GI50 |
|
Anticancer activity against human HOP-92 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human HOP-92 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
Hs-578T
|
GI50 |
|
Anticancer activity against human Hs-578T cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human Hs-578T cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
HT-29
|
GI50 |
|
Anticancer activity against human HT-29 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human HT-29 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
IGROV-1
|
GI50 |
|
Anticancer activity against human IGROV-1 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human IGROV-1 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
Jurkat
|
GI50 |
|
Anticancer activity against human Jurkat cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
Anticancer activity against human Jurkat cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
|
[PMID: 35533562]
|
K562
|
GI50 |
|
Anticancer activity against human K562 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human K562 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
KB 3-1
|
GI50 |
|
Anticancer activity against human KB 3-1 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
Anticancer activity against human KB 3-1 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
|
[PMID: 35533562]
|
KM12
|
GI50 |
|
Anticancer activity against human KM12 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human KM12 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
Lymphocyte
|
GI50 |
|
Cytotoxicity against mitogen activated human peripheral blood lymphocytes assessed as cell growth inhibition incubated for 48 hrs by MTT assay
Cytotoxicity against mitogen activated human peripheral blood lymphocytes assessed as cell growth inhibition incubated for 48 hrs by MTT assay
|
[PMID: 35533562]
|
Lymphocyte
|
GI50 |
|
Cytotoxicity against mitogen activated human peripheral blood lymphocytes assessed as cell growth inhibition incubated for 24 hrs by MTT assay
Cytotoxicity against mitogen activated human peripheral blood lymphocytes assessed as cell growth inhibition incubated for 24 hrs by MTT assay
|
[PMID: 35533562]
|
M14
|
GI50 |
|
Anticancer activity against human M14 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human M14 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
Malme-3M
|
GI50 |
|
Anticancer activity against human Malme-3M cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human Malme-3M cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
MCF7
|
GI50 |
|
Anticancer activity against human MCF7 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human MCF7 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
MCF7
|
GI50 |
|
Anticancer activity against human MCF7 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
Anticancer activity against human MCF7 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
|
[PMID: 35533562]
|
MDA-MB-231
|
GI50 |
|
Anticancer activity against human MDA-MB-231 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human MDA-MB-231 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
MDA-MB-231
|
GI50 |
|
Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
|
[PMID: 35533562]
|
MDA-MB-435
|
GI50 |
|
Anticancer activity against human MDA-MB-435 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human MDA-MB-435 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
MDA-MB-468
|
GI50 |
|
Anticancer activity against human MDA-MB-468 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human MDA-MB-468 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
MOLT-4
|
GI50 |
|
Anticancer activity against human MOLT-4 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human MOLT-4 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
NCI/ADR-RES
|
GI50 |
|
Anticancer activity against human NCI/ADR-RES cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human NCI/ADR-RES cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
NCI-H226
|
GI50 |
|
Anticancer activity against human NCI-H226 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human NCI-H226 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
NCI-H23
|
GI50 |
|
Anticancer activity against human NCI-H23 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human NCI-H23 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
NCI-H322M
|
GI50 |
|
Anticancer activity against human NCI-H322M cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human NCI-H322M cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
NCI-H460
|
GI50 |
|
Anticancer activity against human NCI-H460 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human NCI-H460 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
NCI-H522
|
GI50 |
|
Anticancer activity against human NCI-H522 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human NCI-H522 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
OVCAR-3
|
GI50 |
|
Anticancer activity against human OVCAR-3 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human OVCAR-3 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
OVCAR-4
|
GI50 |
|
Anticancer activity against human OVCAR-4 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human OVCAR-4 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
OVCAR-5
|
GI50 |
|
Anticancer activity against human OVCAR-5 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human OVCAR-5 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
OVCAR-8
|
GI50 |
|
Anticancer activity against human OVCAR-8 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human OVCAR-8 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
PC-3
|
GI50 |
|
Anticancer activity against human PC-3 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human PC-3 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
RPMI-8226
|
GI50 |
|
Anticancer activity against human RPMI-8226 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human RPMI-8226 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
RXF 393
|
GI50 |
|
Anticancer activity against human RXF 393 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human RXF 393 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
SF-268
|
GI50 |
|
Anticancer activity against human SF-268 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SF-268 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
SF-295
|
GI50 |
|
Anticancer activity against human SF-295 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SF-295 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
SF-539
|
GI50 |
|
Anticancer activity against human SF-539 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SF-539 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
SK-MEL-2
|
GI50 |
|
Anticancer activity against human SK-MEL-2 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SK-MEL-2 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
SK-MEL-28
|
GI50 |
|
Anticancer activity against human SK-MEL-28 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SK-MEL-28 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
SK-MEL-5
|
GI50 |
|
Anticancer activity against human SK-MEL-5 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SK-MEL-5 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
SK-OV-3
|
GI50 |
|
Anticancer activity against human SK-OV-3 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SK-OV-3 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
SK-OV-3
|
GI50 |
|
Anticancer activity against human SK-OV-3 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
Anticancer activity against human SK-OV-3 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
|
[PMID: 35533562]
|
SN12C
|
GI50 |
|
Anticancer activity against human SN12C cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SN12C cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
SNB-19
|
GI50 |
|
Anticancer activity against human SNB-19 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SNB-19 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
SR
|
GI50 |
|
Anticancer activity against human SR cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SR cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
SW-620
|
GI50 |
|
Anticancer activity against human SW-620 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SW-620 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
T47D
|
GI50 |
|
Anticancer activity against human T47D cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human T47D cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
TK-10
|
GI50 |
|
Anticancer activity against human TK-10 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human TK-10 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
U-251
|
GI50 |
|
Anticancer activity against human U-251 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human U-251 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
U-251
|
GI50 |
|
Anticancer activity against human U-251 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
Anticancer activity against human U-251 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
|
[PMID: 35533562]
|
UACC-257
|
GI50 |
|
Anticancer activity against human UACC-257 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human UACC-257 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
UACC-62
|
GI50 |
|
Anticancer activity against human UACC-62 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human UACC-62 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|
UO-31
|
GI50 |
|
Anticancer activity against human UO-31 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human UO-31 cells assessed as growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35533562]
|